Sheri Sclabassi

Dr. Sclabassi is currently the CFO and President of Computational Diagnostics Inc., a company that develops neurophysiological monitoring devices used in neuro, cardiovascular, and orthopedic surgeries to help prevent injury during high-risk operations. Her day-to-day responsibilities include overseeing the company’s operations, including accounting and personnel matters, and she has also played an instrumental role in obtaining FDA clearance for the company’s equipment, including CDI’s newest product, NeuroNet-VII.

Her past roles have ranged from managing Robin Williams’ business affairs to becoming one of the first women to serve as a program director for the YMCA. After arriving in Pittsburgh, Sheri became immersed in the city’s tech scene, where she worked as a Product Manager at Actronics, one of the region’s first high-tech startups.

Sheri’s accomplishments extend beyond her professional career and include earning a Ph.D. and an MSW from the University of Pittsburgh, marrying her husband Bob, and raising four sons. In addition to her role on Persad’s Board of Directors, she also serves on the board of the Pittsburgh Opera.